The Role of Myc-induced Protein Synthesis in Cancer

Overview

Journal Cancer Res

Specialty Oncology

Date 2009 Nov 26

PMID 19934336

Citations 107

Authors

Davide Ruggero

Affiliations

Soon will be listed here.

Abstract

Deregulation in different steps of translational control is an emerging mechanism for cancer formation. One example of an oncogene with a direct role in control of translation is the Myc transcription factor. Myc directly increases protein synthesis rates by controlling the expression of multiple components of the protein synthetic machinery, including ribosomal proteins and initiation factors of translation, Pol III and rDNA. However, the contribution of Myc-dependent increases in protein synthesis toward the multistep process leading to cancer has remained unknown. Recent evidence strongly suggests that Myc oncogenic signaling may monopolize the translational machinery to elicit cooperative effects on cell growth, cell cycle progression, and genome instability as a mechanism for cancer initiation. Moreover, new genetic tools to restore aberrant increases in protein synthesis control are now available, which should enable the dissection of important mechanisms in cancer that rely on the translational machinery.

Citing Articles

Targeting protein synthesis pathways in MYC-amplified medulloblastoma.

Kumar D, Kanchan R, Chaturvedi N Discov Oncol. 2025; 16(1):23.

PMID: 39779613 PMC: 11711608. DOI: 10.1007/s12672-025-01761-7.

A toxicogenomics-based identification of potential mechanisms and signaling pathways involved in PFCs-induced cancer in human.

Dehghani Z, Ranjbar S, Shahabinezhad F, Sabouri P, Mohammadi Bardbori A Toxicol Res (Camb). 2024; 13(5):tfae151.

PMID: 39323479 PMC: 11420517. DOI: 10.1093/toxres/tfae151.

Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag.

Tezuka Y, Onoda N, Morishima T, Sumitomo Y, Nishii K, Takizawa H Int J Hematol. 2024; 120(5):575-586.

PMID: 39302624 PMC: 11513719. DOI: 10.1007/s12185-024-03853-6.

MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer.

Meena J, Wang J, Neill N, Keough D, Putluri N, Katsonis P Cancer Discov. 2024; 14(9):1699-1716.

PMID: 39193992 PMC: 11372365. DOI: 10.1158/2159-8290.CD-22-0649.

Patterns of protein synthesis in the budding yeast cell cycle: variable or constant?.

No E, Blank H, Polymenis M Microb Cell. 2024; 11:321-327.

PMID: 39188509 PMC: 11345583. DOI: 10.15698/mic2024.08.835.

References

Johnston L, Prober D, Edgar B, Eisenman R, Gallant P . Drosophila myc regulates cellular growth during development. Cell. 1999; 98(6):779-90. PMC: 10176494. DOI: 10.1016/s0092-8674(00)81512-3. View

Nesbit C, Tersak J, Prochownik E . MYC oncogenes and human neoplastic disease. Oncogene. 1999; 18(19):3004-16. DOI: 10.1038/sj.onc.1202746. View

Schuldiner O, Benvenisty N . A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene. 2001; 20(36):4984-94. DOI: 10.1038/sj.onc.1204459. View

Anderson S, Lauritsen J, Hartman M, Foushee A, Lefebvre J, Shinton S . Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity. 2007; 26(6):759-72. DOI: 10.1016/j.immuni.2007.04.012. View

Pajic A, Spitkovsky D, Christoph B, Kempkes B, Schuhmacher M, Staege M . Cell cycle activation by c-myc in a burkitt lymphoma model cell line. Int J Cancer. 2000; 87(6):787-93. DOI: 10.1002/1097-0215(20000915)87:6<787::aid-ijc4>3.0.co;2-6. View

Petretti C, Savoian M, Montembault E, Glover D, Prigent C, Giet R . The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. EMBO Rep. 2006; 7(4):418-24. PMC: 1456919. DOI: 10.1038/sj.embor.7400639. View

Feldman M, Apsel B, Uotila A, Loewith R, Knight Z, Ruggero D . Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol. 2009; 7(2):e38. PMC: 2637922. DOI: 10.1371/journal.pbio.1000038. View

Oliver E, Saunders T, Tarle S, Glaser T . Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development. 2004; 131(16):3907-20. PMC: 2262800. DOI: 10.1242/dev.01268. View

Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E . Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature. 2008; 456(7224):971-5. PMC: 2880952. DOI: 10.1038/nature07449. View

10.

Mateyak M, Obaya A, Adachi S, Sedivy J . Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 1997; 8(10):1039-48. View

11.

Perez-Roger I, Kim S, Griffiths B, Sewing A, Land H . Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J. 1999; 18(19):5310-20. PMC: 1171601. DOI: 10.1093/emboj/18.19.5310. View

12.

Arabi A, Rustum C, Hallberg E, Wright A . Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J Cell Sci. 2003; 116(Pt 9):1707-17. DOI: 10.1242/jcs.00370. View

13.

Warner J, McIntosh K . How common are extraribosomal functions of ribosomal proteins?. Mol Cell. 2009; 34(1):3-11. PMC: 2679180. DOI: 10.1016/j.molcel.2009.03.006. View

14.

Iritani B, Delrow J, Grandori C, Gomez I, Klacking M, Carlos L . Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1. EMBO J. 2002; 21(18):4820-30. PMC: 126288. DOI: 10.1093/emboj/cdf492. View

15.

Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S, Beyaert R . Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell. 2000; 5(4):597-605. DOI: 10.1016/s1097-2765(00)80239-7. View

16.

Pyronnet S, Sonenberg N . Cell-cycle-dependent translational control. Curr Opin Genet Dev. 2001; 11(1):13-8. DOI: 10.1016/s0959-437x(00)00150-7. View

17.

Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K . c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol. 2005; 7(3):303-10. DOI: 10.1038/ncb1225. View

18.

Kim S, Li Q, Dang C, Lee L . Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc Natl Acad Sci U S A. 2000; 97(21):11198-202. PMC: 17177. DOI: 10.1073/pnas.200372597. View

19.

Grandori C, Gomez-Roman N, Felton-Edkins Z, Ngouenet C, Galloway D, Eisenman R . c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol. 2005; 7(3):311-8. DOI: 10.1038/ncb1224. View

20.

Schlosser I, Holzel M, Murnseer M, Burtscher H, Weidle U, Eick D . A role for c-Myc in the regulation of ribosomal RNA processing. Nucleic Acids Res. 2003; 31(21):6148-56. PMC: 275450. DOI: 10.1093/nar/gkg794. View